Literature DB >> 10755399

Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.

A Osorio1, A Barroso, B Martínez, A Cebrián, J M San Román, F Lobo, M Robledo, J Benítez.   

Abstract

It is estimated that about 5-10% of breast cancer cases may be due to inherited predisposition. Until now, two main susceptibility genes have been identified: BRCA1 and BRCA2. The first linkage and mutational studies suggested that mutations in these two genes would account for the majority of high-risk breast cancer families, but recent studies show how the proportion of families due to BRCA1 or BRCA2 mutations strongly depends on the population and the types of family analyzed. It is now clear that, in the context of families with a modest cancer profile, which are the most commonly found in the clinical practice, the percentage of mutations found is much lower than that suggested by the first studies. In the present study, we analyze a group of 32 Spanish families, which contained at least three cases of female breast cancer (at least one of them diagnosed before the age of 50 years), for the presence of mutations in the BRCA genes. The total proportion of mutations was low (25%), although the percentage of mutations in the BRCA1 and BRCA2 genes was higher, considering the breast and ovarian cancer families and the male breast cancer families respectively. Our results are in agreement with the idea that a great proportion of moderate-risk cancer families could be due to low penetrance susceptibility genes distinct from BRCA1 or BRCA2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10755399      PMCID: PMC2374482          DOI: 10.1054/bjoc.1999.1089

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?

Authors:  O M Serova; S Mazoyer; N Puget; V Dubois; P Tonin; Y Y Shugart; D Goldgar; S A Narod; H T Lynch; G M Lenoir
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

Authors:  F J Couch; M L DeShano; M A Blackwood; K Calzone; J Stopfer; L Campeau; A Ganguly; T Rebbeck; B L Weber
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

3.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

4.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

5.  Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.

Authors:  J Simard; P Tonin; F Durocher; K Morgan; J Rommens; S Gingras; C Samson; J F Leblanc; C Bélanger; F Dion
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

6.  Familial breast cancer and its recognition in an oncology clinic.

Authors:  H T Lynch; P R Fain; D Golgar; W A Albano; J A Mailliard; P McKenna
Journal:  Cancer       Date:  1981-06-01       Impact factor: 6.860

7.  Rapid detection of BRCA1 mutations by the protein truncation test.

Authors:  F B Hogervorst; R S Cornelis; M Bout; M van Vliet; J C Oosterwijk; R Olmer; B Bakker; J G Klijn; H F Vasen; H Meijers-Heijboer
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

8.  Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains.

Authors:  K J Abel; J Xu; G Y Yin; R H Lyons; M H Meisler; B L Weber
Journal:  Hum Mol Genet       Date:  1995-12       Impact factor: 6.150

9.  Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.

Authors:  M R Stratton; D Ford; S Neuhasen; S Seal; R Wooster; L S Friedman; M C King; V Egilsson; P Devilee; R McManus
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

10.  Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.

Authors:  O Díez; A Osorio; M Robledo; A Barroso; M Domènech; J Cortés; J Albertos; J Sanz; J Brunet; J M SanRomán; M C Alonso; M Baiget; J Benítez
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  15 in total

1.  Functional characterization of Ape1 variants identified in the human population.

Authors:  M Z Hadi; M A Coleman; K Fidelis; H W Mohrenweiser; D M Wilson
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

2.  Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics.

Authors:  M de la Hoya; O Díez; P Pérez-Segura; J Godino; J M Fernández; J Sanz; C Alonso; M Baiget; E Díaz-Rubio; T Caldés
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

3.  Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing.

Authors:  Yanfang Guan; Hong Hu; Yin Peng; Yuhua Gong; Yuting Yi; Libin Shao; Tengfei Liu; Gairui Li; Rongjiao Wang; Pingping Dai; Yves-Jean Bignon; Zhe Xiao; Ling Yang; Feng Mu; Liang Xiao; Zeming Xie; Wenhui Yan; Nan Xu; Dongxian Zhou; Xin Yi
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

4.  BRCA1 variants in a family study of African-American and Latina women.

Authors:  Roberta McKean-Cowdin; Heather Spencer Feigelson; Lucy Y Xia; Celeste Leigh Pearce; Duncan C Thomas; Daniel O Stram; Brian E Henderson
Journal:  Hum Genet       Date:  2005-02-23       Impact factor: 4.132

Review 5.  Genetics of disc-related disorders: current findings and lessons from other complex diseases.

Authors:  Annu Näkki; Michele C Battié; Jaakko Kaprio
Journal:  Eur Spine J       Date:  2013-07-10       Impact factor: 3.134

6.  The pathology of hereditary breast cancer.

Authors:  Emiliano Honrado; Javier Benítez; José Palacios
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

7.  Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.

Authors:  Gabriela Torres-Mejía; Robert Royer; Marcia Llacuachaqui; Mohammad R Akbari; Anna R Giuliano; Louis Martínez-Matsushita; Angélica Angeles-Llerenas; Carolina Ortega-Olvera; Elad Ziv; Eduardo Lazcano-Ponce; Catherine M Phelan; Steven A Narod
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-04       Impact factor: 4.254

8.  Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci.

Authors:  Juan Manuel Rosa-Rosa; Guillermo Pita; Miguel Urioste; Gemma Llort; Joan Brunet; Conxi Lázaro; Ignacio Blanco; Teresa Ramón y Cajal; Orland Díez; Miguel de la Hoya; Trinidad Caldés; Maria-Isabel Tejada; Anna González-Neira; Javier Benítez
Journal:  Am J Hum Genet       Date:  2009-01-15       Impact factor: 11.025

Review 9.  Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.

Authors:  Eugenia Yiannakopoulou
Journal:  Cell Oncol (Dordr)       Date:  2013-12-04       Impact factor: 6.730

10.  Family history and breast cancer hormone receptor status in a Spanish cohort.

Authors:  Xuejuan Jiang; Jose Esteban Castelao; Elisabet Chavez-Uribe; Beatriz Fernandez Rodriguez; Catuxa Celeiro Muñoz; Carmen M Redondo; Maite Peña Fernandez; Alejandro Novo Dominguez; Carina Doris Pereira; María Elena Martínez; Tomás García-Caballero; Máximo Fraga Rodriguez; José Antúnez; Angel Carracedo; Jerónimo Forteza-Vila; Manuela Gago-Dominguez
Journal:  PLoS One       Date:  2012-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.